The SIMPL'HIV study investigated whether switching to dolutegravir (DTG) + emtricitabine (FTC) was noninferior to continuing combined antiretroviral therapy for maintaining HIV-1 suppression at 144 weeks. The study demonstrated that viral suppression, CD4 gains, adverse events, quality of life, and patient satisfaction were comparable between groups, confirming DTG + FTC's safety and efficacy for long-term management of HIV-1 infection.
View Article and Find Full Text PDFUnderstanding the origin of bright shooting stars and their meteorite samples is among the most ancient of astronomy-related questions, which at larger scales has human consequences. As of today, only approximately 6% of meteorite falls have been firmly linked to their sources (Moon, Mars or asteroid (4) Vesta). Here we show that approximately 70% of meteorites originate from three recent break-ups of D > 30 km asteroids that occurred 5.
View Article and Find Full Text PDFAims Of The Study: We aimed to assess the extent of SARS-CoV-2 humoral immunity elicited by previous infections and/or vaccination among healthcare workers, and to identify reasons why healthcare workers decided against vaccination.
Methods: This nested cross-sectional study included volunteer healthcare workers from 14 healthcare institutions in German-speaking Switzerland. In January 2021, SARS-CoV-2 vaccines were available for healthcare workers.